Affluent Medical | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Home
Companies
Affluent Medical

PRESS RELEASE

published on 09/12/2024 at 18:44, 2 months 8 days ago

Affluent Medical : Affluent Medical takes stock of its recent operational advances
Affluent Medical reports recent operational advances including agreements with Edwards Lifesciences for medical devices Kalios, Epygon, and Artus. Analysts target price of €4.04 revised upwards

Medical Devices Affluent Medical Target Price Edwards Lifesciences Operational Advances
BRIEF

published on 09/10/2024 at 17:50, 2 months 10 days ago

Affluent Medical: Balance sheet of shares and voting rights as of July 31, 2024

Share Capital Voting Rights Actions AMF Affluent Medical
BRIEF

published on 09/10/2024 at 17:50, 2 months 10 days ago

Affluent Medical: number of shares and voting rights as of August 31, 2024

Euronext Paris Share Capital Voting Rights AMF Affluent Medical
BRIEF

published on 08/22/2024 at 07:35, 2 months 30 days ago

Affluent Medical to Attend German Fall Conference in Frankfurt in September 2024

Affluent Medical Innovative Medical Devices German Fall Conference Christophe De Vregille Financial Milestones
PRESS RELEASE

published on 08/22/2024 at 07:30, 2 months 30 days ago

Affluent Medical to attend German Fall Conference in Frankfurt in September 2024
Affluent Medical to attend German Fall Conference in Frankfurt in September 2024. CFO to present achievements, growth plans, and financial goals at event

Medical Technology Affluent Medical Frankfurt Clinical-stage German Fall Conference
BRIEF

published on 07/15/2024 at 07:50, 4 months 6 days ago

Affluent Medical announces a new capital increase

Euronext Paris Affluent Medical Prospectus Increase In Capital Edwards Life Sciences
PRESS RELEASE

published on 07/15/2024 at 07:45, 4 months 6 days ago

Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights.
Affluent Medical announces availability of a prospectus for trading of 6,190,831 shares in connection with a capital increase without preferential subscription rights. The AMF-approved Prospectus includes details of the Capital Increase

Trading Capital Increase Affluent Medical Prospectus AMF-approved
PRESS RELEASE

published on 07/15/2024 at 07:45, 4 months 6 days ago

Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of
Affluent Medical announces a capital increase without preferential subscription rights involving the trading of 6,190,831 shares. Edwards Lifesciences becomes a 9.21% shareholder after subscribing for €5 million. Risk factors are highlighted in the available prospectus

Capital Increase Affluent Medical Prospectus Risk Factors Trading Shares
BRIEF

published on 07/12/2024 at 07:50, 4 months 9 days ago

Affluent Medical enters into agreements on its mitral valve technologies for 15 million euros

Investment Affluent Medical Edwards Life Sciences Mitral Valve Technology Financial Agreements
PRESS RELEASE

published on 07/12/2024 at 07:45, 4 months 9 days ago

Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
Affluent Medical signs agreements with EUR 15M upfront payment for mitral valve technologies with Edwards Lifesciences, focusing on innovative medical devices and structural heart products

Affluent Medical Agreements Edwards Lifesciences Mitral Valve Technologies EUR 15M

Accesswire

Published on 11/21/2024 at 14:15, 12 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 27 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 27 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 27 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 27 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 10 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 12 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 27 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 11 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 51 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 29 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 7 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 42 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 42 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE